JAMDA
December 27, 2019
Showing 21 - 30 of 2488 results
JAMDA
November 23, 2023
The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use
Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for N...
JAMDA
February 6, 2025
Antipsychotic Use in Older Adults with Dementia: Community and Nursing Facility Trends in Texas, 2015-2020
To assess recent trends in antipsychotic use among older adults with Alzheimer's disease and related dementias (ADRDs) according to their residential status and determine the factors associated with the use of antipsychotics.
Spotlight
July 28, 2025
Third Module of D2D Course Looks at Optimizing Antipsychotic Use
The first two modules in the Drive to Deprescribe (D2D) course—Design Your Deprescribing Intervention and Deprescribing Communication Techniques—have been extremely popular. Based on the initial reaction to the latest module, Optimizing Use of Antipsychotic Medications, PALTmed has another hit on its hands...
JAMDA
November 19, 2021
Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19
Policy Snapshot
August 18, 2025
CMS Temporarily Pauses Nursing Home Care Compare Updates
The Centers for Medicare & Medicaid Services (CMS) has announced a temporary pause in the monthly updates to the Nursing Home Care Compare Five-Star Rating System. This pause is part of CMS’ transition to a new, cloud-based platform, the Internet Quality Improvement and Evaluation System (iQIES). ...
JAMDA
September 18, 2018
Exploring Antipsychotic Prescribing Behaviors for Nursing Home Residents With Dementia: A Qualitative Study
Caution is advised when prescribing antipsychotics to people with dementia. This study explored the determinants of appropriate, evidence-based antipsychotic prescribing behaviors for nursing home residents with dementia, with a view to informing future quality improvement efforts and behavior change inter...
JAMDA
June 27, 2022
Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer’s Disease and Related Dementias: A Cross-Sectional Analysis
We examined the association between nursing home (NH) characteristics and whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing to residents with Alzheimer’s disease and related dementias (ADRD). We then measured the likelihood that NHs who were high (low) prescribers o...
JAMDA
August 6, 2019
When Less is More, but Still Not Enough: Why Focusing on Limiting Antipsychotics in People With Dementia Is the Wrong Policy Imperative
Antipsychotic reductions have been the primary focus of efforts to improve dementia care in nursing homes by the Centers for Medicare & Medicaid Services National Partnership. Although significant antipsychotic reductions have been achieved, this policy focus is myopic in 2 ways; there is no evidence f...
JAMDA
April 28, 2023
Federal Nursing Home Policies on Antipsychotics had Similar Impacts by Race and Ethnicity for Residents With Dementia
Federal initiatives have been successful in reducing antipsychotic exposure in nursing home residents with dementia. We assessed if these initiatives were implemented equally across racial and ethnic minority groups.
